Home -> Law Blog Directory -> Legal Commentary Blogs -> LawPundit
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Legal Commentary
: LawPunditPatent Baristas Comments Extensively on In Re Kubin : The Use of Conventional Techniques to Arrive at an Obvious Result Does Not Make an Invention
By Andis Kaulins
"In In re Kubin (08-1184), the US Court of Appeals for the Federal Circuit held that the US Patent and Trademark Office's Board of Patent Appeals and Interferences was correct to hold claims as unpatentably obvious when applicants use "conventional techniques" to make an invention. This is bad news not just for biotech but for all arts."
The discussion by Albainy-Jenei is a good one, so be sure to read it, although we think that In re Kubin is not going to be long-term bad news for biotech or for the arts. The Federal Circuit in In re Kubin, following the United States Supreme Court's new obviousness standard in KSR, simply has finally drawn an understandable and desperately needed line for biotechnology patent applications - this far and no further. Not every foreseeable - obvious - increase in our scientific knowledge is - or should be - subject to patent protection. There is something we might call the "normal" progress of science - and that - to our mind - is not invention.
The patent situation in biotechnology has gotten as much out of hand as in the rest of the patent world. We need merely to refer to the Google Public Policy Blog where After the last time I blogged about patent reform in late 2007, the House went on to approve the Patent Reform Act. The bill unfortunately got bogged down in the Senate the following year. Since then the problems of the current system ? and the need for reform ? have only grown.
Consider this: Of the 20 patent lawsuits filed against Google since late 2007, all but two have been filed by plaintiffs who don?t make or sell any real product or service ? in other words, by non-practicing entities or ?patent trolls.? Most of these cases seem to feature the same small set of contingent fee plaintiff's lawyers asserting patent claims against the same small set of companies. We've also noticed a more disturbing trend: in many of these cases, the patents being asserted against us are owned by ? and in a surprising number of cases, are even ?invented? by ? patent lawyers themselves.
Unfortunately, the temptations and opportunities for abuse have gotten too high. Lawyers and plaintiffs have seen the potentially huge payoffs available in patent litigation. Before 1990, there had been just one patent damage award of over $100 million. Since 1990, there have been at least 15, with at least five topping $500 million.
Full post as published by LawPundit on April 17, 2009 (boomark / email).
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Miami Beach Drownings Result in $5.75 Million Settlement
Miami Beach Drownings Result in $5.75 Million Settlement
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
Online Ticket Vendor
Buying Tickets Online That Never Arrive
Davison and Associates
Invention Promoters to Pay $10 Million in FTC Settlement
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.

Court: Its Not An Invention If You Use Conventional Techniques To Make It
Obvious to Try BIO Challenges Ex Parte Kubin
In re Kubin: Federal Circuit Expands Obvious to Try Jurisprudence
In re Kubin: Federal Circuit Expands Obvious-to-Try Jurisprudence
Patent Docs post on Kubin, for which oral argument is Jan. 8








